September 2025
1. DE OLIVEIRA THA, Anderson LA, Craig SG, Coleman HG, et al
   Methodological considerations in assessing HPV prevalence in Barrett's oesophagus progression.
   Br J Cancer. 2025 Sep 19. doi: 10.1038/s41416-025-03168.
   

   >> Share

   
   
2. GORI S, Venturelli F, Carozzi F, Giorgi Rossi P, et al
   Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology.
   Br J Cancer. 2025 Sep 11. doi: 10.1038/s41416-025-03161.
   

   >> Share

   
   
3. MATHEWS CS, Sargent A, Cuschieri K, Rebolj M, et al
   HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devices.
   Br J Cancer. 2025;133:665-673.
   

   >> Share

   
   July 2025
4. SIMBA H, McCormack V, Bilaba J, Mmbaga BT, et al
   Non-melanoma skin cancer and HPV in persons with albinism: a call for research investment.
   Br J Cancer. 2025 Jul 4. doi: 10.1038/s41416-025-03107.
   

   >> Share

   
   June 2025
5. DE OLIVEIRA THA, Anderson LA, Craig SG, Coleman HG, et al
   Infectious agents and progression from Barrett's oesophagus to oesophageal adenocarcinoma: a nested case-control study.
   Br J Cancer. 2025;132:1050-1055.
   

   >> Share

   
   April 2025
6. SU H, Jin X, Kong L, You Y, et al
   The triage role of cytological DNA methylation in women with non-16/18, specifically genotyping high-risk HPV infection.
   Br J Cancer. 2025 Apr 10. doi: 10.1038/s41416-025-03005.
   

   >> Share

   
   May 2024
7. OLIVA M, Heirali A, Watson G, Rooney AM, et al
   Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
   Br J Cancer. 2024 May 7. doi: 10.1038/s41416-024-02701.
   

   >> Share

   
   
8. REBOLJ M, Brentnall AR, Cuschieri K
   Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
   Br J Cancer. 2024;130:1733-1743.
   

   >> Share

   
   April 2024
9. TABATABAEIAN H, Bai Y, Huang R, Chaurasia A, et al
   Navigating therapeutic strategies: HPV classification in head and neck cancer.
   Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02655.
   

   >> Share

   
   January 2024
10. WANG Y, He M, He T, Ouyang X, et al
    Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
    Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555.
    

    >> Share

    
    
11. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
    Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
    Br J Cancer. 2024 Jan 8. doi: 10.1038/s41416-023-02521.
    

    >> Share

    
    November 2023
12. DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al
    Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
    Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490.
    

    >> Share

    
    October 2023
13. LO CIGNO I, Calati F, Girone C, Borgogna C, et al
    SIRT1 is an actionable target to restore p53 function in HPV-associated cancer therapy.
    Br J Cancer. 2023 Oct 14. doi: 10.1038/s41416-023-02465.
    

    >> Share

    
    August 2023
14. CUSCHIERI K, Palmer T, Graham C, Cameron R, et al
    The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland.
    Br J Cancer. 2023 Aug 10. doi: 10.1038/s41416-023-02386.
    

    >> Share

    
    April 2023
15. VERHOEF L, Bleeker MCG, Polman N, Steenbergen RDM, et al
    Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
    Br J Cancer. 2023 Apr 26:1-8. doi: 10.1038/s41416-023-02277.
    

    >> Share

    
    
16. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2023 Apr 13. doi: 10.1038/s41416-023-02261.
    

    >> Share

    
    
17. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
    Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
    Br J Cancer. 2023 Apr 12. doi: 10.1038/s41416-023-02240.
    

    >> Share

    
    March 2023
18. MITTELSTADT S, Kelemen O, Admard J, Gschwind A, et al
    Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.
    Br J Cancer. 2023 Mar 27. doi: 10.1038/s41416-023-02233.
    

    >> Share

    
    
19. GILHAM C, Sargent A, Crosbie EJ, Peto J, et al
    Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester.
    Br J Cancer. 2023 Mar 23. doi: 10.1038/s41416-023-02227.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share